Strongly enhanced toxicity of the mushroom toxin α-amanitin by an 
amatoxin-specific Fab or monoclonal antibody

Faulstich, Heinz; Kirchner, Karin; Derenzini, Massimo

doi:10.1016/0041-0101(88)90188-2

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Strongly enhanced toxicity of the mushroom toxin α-amanitin by an amatoxin-specific Fab or monoclonal antibody

MPS-Authors

/persons/resource/persons92864

Faulstich, Heinz
Department of Physiology, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons248990

Kirchner, Karin
Max Planck Institute for Medical Research, Max Planck Society;

External Resource

https://www.sciencedirect.com/science/article/pii/0041010188901882
(全文テキスト（全般）)

https://www.sciencedirect.com/science/article/pii/0041010188901882/pdf?md5=3de7ebccd34d18bcc664cc2538070e10&pid=1-s2.0-0041010188901882-main.pdf
(全文テキスト（全般）)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Faulstich, H., Kirchner, K., & Derenzini, M. (1988). Strongly enhanced toxicity of the mushroom toxin α-amanitin by an amatoxin-specific Fab or monoclonal antibody. Toxicon, 26(5), 491-499. doi:10.1016/0041-0101(88)90188-2.

引用: https://hdl.handle.net/21.11116/0000-000A-9FE4-2

要旨

H. Faulstich, K. Kirchiner and M. Derenzini. Strongly enhanced toxicity of the mushroom toxin α-amanitin by an amatoxin-specific Fab or monoclonal antibody. Toxicon26, 491–499, 1988. — A monoclonal antibody, with high affinity against the mushroom toxin α-amanitin, was prepared. Administration of the Fab fragment of the monoclonal antibody to mice caused a 50-fold increase in α-amanitin toxicity. Electron micrographs showed normal appearance of hepatocytes but typical, amanitin-induced lesions in cells of the proximal convoluted tubules of the kidney. The pronounced nephrotoxicity is mainly explained by glomerular filtration and tubular reabsorption of the Fab-amatoxin complex and, to a lesser extent, of the immunoglobulin — amatoxin complex, which is still c. twice as toxic as free α-amanitin. To our knowledge this is the first reported case where immunoglobulins or their fragments enhance rather than decrease the activity of a toxin. Accordingly, immunotherapy of Amanita mushroom poisoning in humans does not appear promising.